COLUMBIA, Md., April 26 /PRNewswire-FirstCall/ -- DHA omega-3 innovator Martek Biosciences Corporation announced today an agreement with Breyers Yogurt Company, a wholly-owned subsidiary of Healthy Food Holdings, a management holding company focused on healthy, natural and organic products. Under the terms of the 15-year agreement, Breyers Yogurt Company has agreed to purchase, subject to certain limited exceptions, all of its DHA omega-3 needs from Martek for products in the United States and other designated territories. There are no minimum purchase requirements or other financial commitments to Martek. For all products containing life'sDHA(TM), Breyers Yogurt Company will display the life'sDHA(TM) logo on the product packaging, and will also include the life'sDHA(TM) logo in related marketing, advertising and promotional materials.
"DHA is an ingredient that has been shown to provide important brain, eye and heart health benefits across the lifecycle and we are looking forward to making this nutrient more available to U.S. families," said Chuck Marcy, president and CEO of Healthy Food Holdings.
"Martek finds it rewarding to partner with an innovator in the healthy foods category and we look forward to working with Breyers Yogurt Company to make DHA, an important nutrient throughout the lifecycle, more available to consumers," said Steve Dubin, CEO of Martek Biosciences. "I applaud Breyers Yogurt Company for recognizing the health benefits of Martek's life'sDHA(TM), and believe that this agreement marks another step towards the widespread use of Martek's life'sDHA(TM) in a variety of food and beverage products."
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye function, and there are studies currently underway to investigate its role in decreasing the prevalence of certain neurological disorders. Yet despite its importance, Americans have among the lowest dietary intakes of DHA omega-3 in the world.
Martek's life'sDHA(TM) is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life'sDHA(TM) is free of oceanic contaminants that may be present in certain fish or fish oils. Microalgae are the only vegetarian source of DHA omega-3, the key omega-3 for brain and eye development and function.
Martek Biosciences Corporation (NASDAQ: MATK - News) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The Company also produces ARA (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com/.
Sections of this release contain forward-looking statements concerning, among other things, expectations regarding product launches by Breyers Yogurt Company, customer acceptance of products with Martek's life'sDHA(TM), and widespread use of Martek's life'sDHA(TM). These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.